Benlysta Infusion
Belimumab
400mg/vial
GLAXO GROUP LIMITED
| Pack size | 20ml Glass Vial |
|---|---|
| Dispensing mode | POM |
| Source | UK |
| Agent | Modern Pharmaceutical Co. |
| Retail Price | 1649.50 AED |
Available as:
Indications
Benlysta Infusion is used for:
Adjunct treatment for auto-antibody-positive active systemic lupus erythematosus.
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Belimumab :
Mechanism of Action
Belimumab selectively binds to soluble human B lymphocyte stimulator protein (BLyS) so that BLyS is unable to bind to receptors on B lymphocytes. The binding of BLyS to its receptor is essential for the survival of B lymphocytes. Consequently, belimumab reduces B-cell mediated immunity and the autoimmune response.
Note
Benlysta 400mg/vial Infusion manufactured by GLAXO GROUP LIMITED. Its generic name is Belimumab. Benlysta is availble in United Arab Emirates.
Farmaco UAE drug index information on Benlysta Infusion is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.